EEG反应性与病因作为α和θ昏迷的预后修饰因素:系统评价与Meta分析
该系统评价与Meta分析纳入6项研究共152例α/θ昏迷患者,评估功能结局与预后修饰因素。结果显示83.7%出现严重残疾或死亡,死亡率为74.0%,EEG反应性存在率为45.4%。无反应EEG与死亡率显著相关(OR 5.67),反应性EEG与良好结局几率增加相关(OR 8.68)。缺氧缺血性损伤占主导,而中毒或代谢性病因在结局较好患者中更常见。α/θ昏迷预后存在异质性,需结合EEG反应性和病因进行判断。
要点
- 总体预后仍差:83.7%患者严重残疾或死亡,死亡率74.0%(95%CI 43.2-91.4%)。
- EEG无反应与死亡率显著相关(OR 5.67,95%CI 1.22-26.31),且降低良好结局几率(OR 0.12,95%CI 0.03-0.48)。
- EEG有反应与良好结局几率增加相关(OR 8.68,95%CI 2.08-36.24),但不保证恢复。
- 缺氧缺血性损伤是最常见病因,中毒或代谢性病因在结局较好患者中更常见。
- 历史诊断定义与当代意识障碍概念可能不一致,解读结果需谨慎。
适用人群与场景
- 深度昏迷患者中出现α昏迷、θ昏迷或α-θ昏迷EEG模式者;研究纳入原始人类研究,排除标准原文未提及。
诊断标准与关键阈值
- α/θ昏迷的诊断基于EEG模式,具体标准原文未提及;EEG反应性为预设的预后分析因素,检测方法原文未提及。
处置流程与药物剂量
- 原文未提及
红旗征与不能漏的情况
- 原文未提及
研究设计与关键结果
- 研究类型:系统评价与Meta分析;纳入6项研究,共152例患者。
- 主要结局:83.7%(95%CI 76.8-88.8%,I2=21.6%)经历严重残疾或死亡;死亡率74.0%(95%CI 43.2-91.4%,I2=41.3%)。
- EEG反应性存在率为45.4%(95%CI 24.0-68.6%,I2=52.2%)。
- 无反应EEG与死亡率相关(OR 5.67,95%CI 1.22-26.31,I2=0%),与良好结局几率降低相关(OR 0.12,95%CI 0.03-0.48)。
- 反应性EEG与良好结局几率增加相关(OR 8.68,95%CI 2.08-36.24)。
- 病因分布:缺氧缺血性损伤占主导,中毒或代谢性病因在结局较好患者中更频繁。
证据类型、等级与局限
- 证据类型:系统评价与Meta分析;证据等级或推荐强度原文未提及。
- 局限:纳入研究数量少(6项),样本量小(n=152),历史诊断不确定性,研究间异质性(I2部分较高),原文指出需当代研究重新定义α/θ昏迷。
对床旁实践的改变
- 对于α/θ昏迷患者,应评估EEG反应性以协助预后判断:无反应者死亡风险更高(OR 5.67),反应者良好结局几率更高(OR 8.68),但反应性不保证恢复。
- 病因评估重要:缺氧缺血性损伤预后较差,中毒或代谢性病因预后相对较好。
- 解读预后时需考虑历史诊断定义与当代意识障碍概念的差异,避免过度悲观。
指南或共识出处
- 原文未提及指南或共识名称;本文为系统评价与Meta分析,检索PubMed、EMBASE和Cochrane数据库至2025年12月。
以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Alpha/theta coma is an uncommon electroencephalographic (EEG) pattern observed in deeply comatose patients and has traditionally been regarded as a malignant finding, particularly after hypoxic-ischemic injury following cardiac arrest. Classically, it is associated with a nonreactive alpha/theta rhythm and high mortality. However, occasional neurological recovery suggests greater prognostic heterogeneity than historically believed, while it remains uncertain whether historical diagnostic definitions of alpha/theta coma are comparable with contemporary concepts of disorders of consciousness. We conducted a systematic review and meta-analysis to clarify outcome heterogeneity, identify prognostic modifiers associated with recovery, and re-appraise the historical literature.
METHODS: A systematic search of PubMed, EMBASE, and Cochrane databases was conducted through December 2025. Original human studies reporting outcomes in comatose patients with alpha coma, theta coma, or alpha-theta coma were included. Functional outcomes were categorized into four ordinal categories. Random- or common-effects models were applied according to heterogeneity. Prespecified prognostic analyses focused on EEG reactivity.
RESULTS: Six studies (n = 152) were included. Overall, 83.7% (95% CI 76.8-88.8%, I2 = 21.6%) experienced severe disability or death, and mortality was 74.0% (95% CI 43.2-91.4, I2 = 41.3%). EEG reactivity was present in 45.4% (95% CI 24.0-68.6%, I2 = 52.2%). Nonreactive EEG was significantly associated with mortality (OR 5.67, 95% CI 1.22-26.31, I2 = 0%) and reduced odds of good outcome (OR 0.12, 95% CI 0.03-0.48). Reactive EEG was associated with increased odds of favorable outcome (OR 8.68, 95%, CI 2.08-36.24). Hypoxic-ischemic injury predominated, whereas toxic or metabolic etiologies were more frequent among patients with better outcomes.
CONCLUSIONS: Alpha/theta coma is not uniformly fatal. EEG reactivity identifies a lower-risk subgroup without guaranteeing recovery, while etiology further shapes prognosis. These findings should be interpreted in the context of historical diagnostic uncertainty, and contemporary studies are needed to better define alpha/theta coma using current concepts of disorders of consciousness.
参考来源
- Phutinart S, Kedgan P, Kosonboon P, et al. EEG Reactivity and Etiology as Prognostic Modifiers in Alpha and Theta Coma: A Systematic Review and Meta-analysis. Neurocrit Care. 2026. PMID: 42711629. doi:10.1007/s12028-026-02646-5
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。